基本信息
views: 39
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I’m privileged to work as a medical oncologist and cancer researcher. I work for people with melanoma, brain, prostate, bladder and kidney cancers at the Calvary Mater Newcastle, and on secondment from the Hunter Medical Research Institute to NSW Regional Health Partners.
I feel humbled when a treatment works for a patient; but feel very frustrated when a treatment fails. My research focus is on complexity and heterogeneity in cancer – why are cancers different between different people; why are cancers cells different to each other; what does this mean for each person’s treatment? This challenging problem spans projects across the research spectrum, from patient experience, through clinical trials, translational biomarkers and questions in basic science.
I’m very fortunate to lead several national cancer clinical trials for the ANZUP and COGNO cancer trials groups, to chair the ANZUP Renal Cancer Subcommittee, and to contribute as a member of the Mark Hughes Scientific Advisory Committee, HNEHLD Clinical Trials Ethics Subcommittee, COGNO Scientific Advisory Committee and ANZUP Cancer Trials Scientific Advisory Committee.
Research Interests
Papers共 139 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
BJU INTERNATIONAL (2024): 57-67
European Urology Focus (2024)
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 4569-4569
The Lancet. Oncologyno. 1 (2023): 99-107
crossref(2023)
crossref(2023)
JOURNAL OF CLINICAL ONCOLOGY (2023)
Cited0Views0Bibtex
0
0
The Lancet. Oncologyno. 8 (2023): 881-891
Load More
Author Statistics
#Papers: 140
#Citation: 3358
H-Index: 27
G-Index: 57
Sociability: 7
Diversity: 3
Activity: 49
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn